Format

Send to

Choose Destination
Ann Intern Med. 2011 May 17;154(10):680-3. doi: 10.7326/0003-4819-154-10-201105170-00008.

Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions.

Author information

1
Harvard School of Public Health, Boston, Massachusetts 02115, USA. tvanderw@hsph.harvard.edu

Abstract

In randomized trials with subgroup analyses, the primary treatment or intervention of interest is randomized, but the secondary factors defining subgroups are not. This article clarifies when confounding is an issue in subgroup analyses. If investigators are interested simply in targeting subpopulations for intervention, control for confounding is not needed. If investigators are interested in intervening on the secondary factors that define the subgroups to increase the treatment effect or in attributing the subgroup differences to the secondary factors themselves, then confounding is relevant and must be controlled for. The authors demonstrate this point by using examples from published randomized trials.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center